Experimental coronavirus drug “Remdesivir” halts new trials due to high demand

New patients are not being granted access to the experimental coronavirus drug “Remdesivir” due to “overwhelming demand,” said Gilead Sciences on Sunday. Gilead Sciences is the company behind the COVID-19 clinical trials of Remdesivir, a drug that was used during the Ebola outbreak. A new study recently revealed that the drug may be effective against COVID-19 due to the fact that this drug was previously known to be effective against some coronaviruses.

The study was published in the Journal of Biological Chemistry, after scientists found that the drug was effective against other coronaviruses such as MERS and SARS. Gilead Sciences said in a company statement that it is focusing on improving the approval process for new patients to achieve a similar timeframe and processing previously approved requests for the drug. The company will make exceptions for pregnant women and children under the age of 18 who are confirmed with COVID-19 and “severe manifestations” of the coronavirus.

Gilead Sciences Remdesivir
Gilead Sciences, headquartered in Foster City, California. | Image: David Paul Morris/Bloomberg via Getty Images

Clinical trials for Remdesivir are being conducted in five large groups, two of which could produce results in early April. According to the company, the drug has been provided to hundreds of patients in the United States, Europe, and Japan. “Enrollment in clinical trials is the primary way to access remdesivir to generate critical data that inform the appropriate use of this investigational medicine,” the company says in a statement.

The Remdesivir trials were not designed for a pandemic

The system is still not perfect, as Gilead Sciences acknowledges that some severely ill patients will not be able to enroll in the clinical trials. However, the company is moving towards a “compassionate use” system, to help expand programs for access to the drug. Gilead Sciences is also working with regulators to rapidly develops these programs. The company also notes that there has been “an exponential increase” in requests for compassionate use, as the number of cases begins to increase exponentially in the United States and Europe.

This sudden demand is what caused the company to pause approval of new requests as it works on improving its system. Gilead Sciences also says that the treatment access system that provides limited access to the experimental drug was “never intended for use in response to a pandemic.”

Can Remdesivir stop the pandemic?

Even if everything goes well, the mechanism of action of Remdesivir is poorly understood.  Some studies suggest that the drug positively binds to the mRNA chain in viral synthesis. Such binding prevents the virus from replicating, thereby stopping the virus. However, reports suggest that even then, a combination of drugs will be required to stop the novel coronavirus pandemic that we are facing now.

Without the knowledge of any other options, Remdesivir may be our best chance at fighting this pandemic. A recent report at the New England Journal of Medicine shows that a person administered with Remdesivir recovered on the seventh day of illness. Also, in a recent press meeting conference, the Director-General of WHO said Remdesivir may be only available drug effective against Remdesivir.

Join our writing team and develop your writing skills, as you see your articles featured on Apple NewsGoogle News, and all around the worldSubscribe to our newsletter, What Just Happened, where we dive deep into the hottest topics from the week!

Source: Stat

More from Coronavirus – News Landed

+ COVID-19 pandemic halts NASA’s James Webb Space Telescope development

Why is the coronavirus killing more men than women, especially in Italy?

Lockdown in Italy gets tighter as 627 people die in a day

Google launches a COVID-19 search portal with safety tips

Amazon making major profits amid the economic impact of coronavirus pandemic

A new study suggests that an old malarial drug can help fight the coronavirus

Coronaviruses also exist in dogs, cats, bats, and whales

WHO takes back warning against use of ibuprofen on COVID-19 patients

Popular Stories – News Landed

The Platform: A sci-fi, dystopian Spanish film that highlights inequality

Who opened this burial chamber, and who stole the mummy?

Apex AP-0: A sportier EV from a new company

Related Stories

Will Telosa be the “City of the Future” by 2030?

Shenzhen, China was a sleepy fishing village in 1979. A mere forty years later, it is one of the...

Low-cost lead adsorbing water filter designed by Indian students

Two students from India have designed a low-cost lead water filter that can be made with locally sourced materials....

Featured Stories

Will Telosa be the “City of the Future” by 2030?

Shenzhen, China was a sleepy fishing village in 1979. A mere forty years later, it is one of the...

Low-cost lead adsorbing water filter designed by Indian students

Two students from India have designed a low-cost lead water filter that can be made with locally sourced materials....

Make it Rain! Dubai uses drones to conjure rain from the skies

You can order food, hail a driver, and even find a spouse with the click of a button; but...

Physicists have created the world’s thinnest magnet. Just one atom thick!

Can you guess the size of the thinnest magnet? It is just one atom thick. Scientists from the University of...

Boris Johnson and Rishi Sunak reverse decision to avoid self-isolation following ping by NHS contact tracing

Following the Health Secretary's diagnosis with COVID-19, the Prime Minister and Chancellor were notified by NHS Test and Trace...

India is one of the largest producers of COVID vaccine and yet faces major internal shortages

The worsening situation in India finally gained some stabilization around September 2020. Usually, when things start getting better, people...